China’s COVID-19 drugs pipeline focuses on new sub-variants, says GlobalData https://ift.tt/urKBIb1

As per GlobalData’s Pharma Intelligence Centre, there are 19 drugs in various phases of clinical development for the treatment of COVID-19 in China. Most of these drugs are targeting various subtypes of COVID-19 variants such as Delta and Omicron.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Jv3UnXe
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.